Gapping up
In reaction to earnings/guidance:
- APOG +6.6%, KMX +6.1%, SWBI +5.3% (also increases dividend)
Other news:
- TRUP +15.8% (provides update on its rate filing approval status in CA and NY)
- MGTX +9.3% (to present data from Phase 1 AQUAx study and provide update on phase 2 study of AAV-hAQP1)
- IONQ +9.3% (increases its 2023 bookings expectations by 25%)
- GSK +5.4% (provides Zantac litigation update)
- ICPT +4.1% (receives Complete Response Letter from FDA for obeticholic acid as a treatment for pre-cirrhotic fibrosis due to NASH; to restructure to focus on rare and serious liver diseases; significantly reduces operating expenses)
- EGLE +3.9% (to repurchase Oaktree Capital's entire 28% stake for $219.3 mln)
- MMM +3.8% (enters into broad class resolution to support PFAS remediation)
- BC +2.1% (provides update on previously reported IT security incident)
- SAH +1.5% (suspends operations at eight EchoPark locations)
Analyst comments:
- W +2.5% (upgraded to Market Perform from Underperform at MoffettNathanson)